Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut.

PubWeight™: 2.49‹?› | Rank: Top 2%

🔗 View Article (PMID 10232648)

Published in Am J Clin Nutr on May 01, 1999

Authors

M D Collins1, G R Gibson

Author Affiliations

1: Microbiology Department, the Institute of Food Research, Reading, United Kingdom.

Articles citing this

Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol (2001) 3.49

Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int (2010) 2.51

Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 2.43

Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol (2007) 1.94

Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol (2005) 1.87

Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol (2005) 1.81

Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Appl Environ Microbiol (2000) 1.78

Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol (2006) 1.70

Genomic insights into bifidobacteria. Microbiol Mol Biol Rev (2010) 1.57

Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. Am J Physiol Gastrointest Liver Physiol (2014) 1.57

Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin Wochenschr (2007) 1.51

Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg (2006) 1.48

Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS One (2015) 1.43

Characterization of microbial communities found in the human vagina by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes. Appl Environ Microbiol (2005) 1.29

Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract (2012) 1.25

Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010. Appl Environ Microbiol (2004) 1.21

Metabolism of fructooligosaccharides by Lactobacillus paracasei 1195. Appl Environ Microbiol (2003) 1.16

Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol (2010) 1.14

Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt) (2009) 1.14

Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis (2008) 1.11

Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol (2008) 1.10

Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol (2010) 1.10

Ecological succession of bacterial communities during conventionalization of germ-free mice. Appl Environ Microbiol (2012) 1.09

High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed (2004) 1.02

Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther (2011) 1.02

The human neonatal gut microbiome: a brief review. Front Pediatr (2015) 1.01

Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg (2005) 1.01

Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci (2008) 0.98

Adhesion of bifidobacteria to granular starch and its implications in probiotic technologies. Appl Environ Microbiol (2001) 0.98

Purification, crystallization and preliminary X-ray analysis of the galacto-N-biose-/lacto-N-biose I-binding protein (GL-BP) of the ABC transporter from Bifidobacterium longum JCM1217. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.97

Colonization and impact of disease and other factors on intestinal microbiota. Dig Dis Sci (2007) 0.94

Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci (2001) 0.90

Bifidobacterial diversity determined by culturing and by 16S rDNA sequence analysis in feces and mucosa from ten healthy Spanish adults. Dig Dis Sci (2006) 0.89

Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World J Gastroenterol (2008) 0.89

Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int (2007) 0.89

A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr (2011) 0.88

Role of Enteric Supplementation of Probiotics on Late-onset Sepsis by Candida species in Preterm Low Birth Weight Neonates: A Randomized, Double Blind, Placebo-controlled Trial. N Am J Med Sci (2014) 0.88

Host-derived pentapeptide affecting adhesion, proliferation, and local pH in biofilm communities composed of Streptococcus and Actinomyces species. Infect Immun (2006) 0.87

Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front Physiol (2012) 0.87

Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial. Surg Today (2015) 0.86

Lupin kernel fiber consumption modifies fecal microbiota in healthy men as determined by rRNA gene fluorescent in situ hybridization. Eur J Nutr (2006) 0.86

Optimization of cholesterol removal by probiotics in the presence of prebiotics by using a response surface method. Appl Environ Microbiol (2005) 0.84

Proteomic comparison of the cytosolic proteins of three Bifidobacterium longum human isolates and B. longum NCC2705. BMC Microbiol (2010) 0.84

Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014. World Allergy Organ J (2016) 0.83

Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol (2006) 0.82

Monitoring healthy metabolic trajectories with nutritional metabonomics. Nutrients (2009) 0.82

Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats. World J Gastroenterol (2005) 0.81

Quantitative detection of viable Bifidobacterium bifidum BF-1 cells in human feces by using propidium monoazide and strain-specific primers. Appl Environ Microbiol (2013) 0.81

Flavor, relative palatability and components of cow's milk hydrolysed formulas and amino acid-based formula. Ital J Pediatr (2015) 0.80

Improved parameters of lactose maldigestion using lactulose. Dig Dis Sci (2001) 0.80

The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/- mice. PLoS One (2013) 0.80

Evaluation of functional aspects of Lactobacillus fermentum CFR 2195 isolated from breast fed healthy infants' fecal matter. J Food Sci Technol (2011) 0.79

Construction of Bacillus subtilis strain engineered for expression of porcine β-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity. Asian-Australas J Anim Sci (2016) 0.78

Enteric Pathogens Exploit the Microbiota-generated Nutritional Environment of the Gut. Microbiol Spectr (2015) 0.78

Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect. Front Microbiol (2016) 0.78

Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis. Inflammation (2009) 0.78

Evolution of probiotics in aquatic world: Potential effects, the current status in Egypt and recent prospectives. J Adv Res (2013) 0.77

Bifidobacterium longum HY8004 attenuates TNBS-induced colitis by inhibiting lipid peroxidation in mice. Inflamm Res (2009) 0.77

Effects of Bifidobacterium bifidum G9-1 on Nasal Symptoms in a Guinea Pig Model of Experimental Allergic Rhinitis. Biosci Microflora (2010) 0.76

Cocktails of probiotics pre-adapted to multiple stress factors are more robust under simulated gastrointestinal conditions than their parental counterparts and exhibit enhanced antagonistic capabilities against Escherichia coli and Staphylococcus aureus. Gut Pathog (2015) 0.76

Prebiotics Do Not Influence the Severity of Atopic Dermatitis in Infants: A Randomised Controlled Trial. PLoS One (2015) 0.76

Isolation and microencapsulation of Lactobacillus spp. from corn silage for probiotic application. Iran J Microbiol (2010) 0.76

Exogenous lactobacilli mitigate microbial changes associated with grain fermentation (corn, oats, and wheat) by equine fecal microflora ex vivo. PLoS One (2017) 0.75

Enhanced Probiotic Potential of Lactobacillus reuteri When Delivered as a Biofilm on Dextranomer Microspheres That Contain Beneficial Cargo. Front Microbiol (2017) 0.75

The effect of bacteria, enzymes and inulin on fermentation and aerobic stability of corn silage. Iran J Microbiol (2012) 0.75

Preparation of epithelial and mesenchymal stem cells from murine mammary gland. Curr Protoc Toxicol (2011) 0.75

Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model. Antimicrob Agents Chemother (2016) 0.75

Identification of Antihypertensive Peptides Derived from Low Molecular Weight Casein Hydrolysates Generated during Fermentation by Bifidobacterium longum KACC 91563. Korean J Food Sci Anim Resour (2015) 0.75

Growth performance, nutrients digestibility, and blood metabolites of lambs fed diets supplemented with probiotics during pre- and post-weaning period. Asian-Australas J Anim Sci (2016) 0.75

Normal growth of infants receiving an infant formula containing Lactobacillus reuteri, galacto-oligosaccharides, and fructo-oligosaccharide: a randomized controlled trial. Matern Health Neonatol Perinatol (2015) 0.75

Diversity of key players in the microbial ecosystems of the human body. Sci Rep (2015) 0.75

Market Assessment and Product Evaluation of Probiotic Containing Dietary Supplements Available in Bangladesh Market. J Pharm (Cairo) (2015) 0.75

Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial. Pediatr Res (2016) 0.75

Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation. BMC Microbiol (2017) 0.75

Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog (2017) 0.75

Articles by these authors

(truncated to the top 100)

Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09

Isolation of Helicobacter pylori from human faeces. Lancet (1992) 7.32

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61

Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol (1992) 2.87

Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78

Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology (1992) 2.34

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13

The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr (1998) 2.11

Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol (1993) 1.87

Metabolism of dietary sulphate: absorption and excretion in humans. Gut (1991) 1.85

Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology (1994) 1.73

Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett (2000) 1.65

Influence of mode of delivery on gut microbiota composition in seven year old children. Gut (2004) 1.55

The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides--a human volunteer study. Br J Nutr (2001) 1.50

Probiotics as modulators of the gut flora. Br J Nutr (2002) 1.46

A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr (2007) 1.38

Influence of mucin on glycosidase, protease and arylamidase activities of human gut bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol (1989) 1.35

Clostridium hathewayi sp. nov., from human faeces. Syst Appl Microbiol (2001) 1.34

Prebiotic effects of inulin and oligofructose. Br J Nutr (2002) 1.28

Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut (1992) 1.24

Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol Suppl (1997) 1.24

The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutr Rev (1993) 1.24

A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol (2001) 1.23

A novel mucin sulphatase from human faeces: its identification, purification and characterization. Clin Sci (Lond) (1992) 1.23

Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. J Appl Bacteriol (1990) 1.22

Modulation of the human gut microflora towards improved health using prebiotics--assessment of efficacy. Curr Pharm Des (2005) 1.18

Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr (2011) 1.17

Nutritional aspects of dissimilatory sulfate reduction in the human large intestine. Curr Microbiol (1997) 1.12

Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res (2001) 1.10

Formation of glycoprotein degrading enzymes by Bacteroides fragilis. FEMS Microbiol Lett (1991) 1.10

Methemoglobinemia produced by high-dose intravenous nitroglycerin. Ann Intern Med (1982) 1.10

Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol (2001) 1.09

Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol (2002) 1.09

In vitro fermentation by human fecal microflora of wheat arabinoxylans. J Agric Food Chem (2007) 1.06

Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol (2001) 1.04

Experimental use of cetrimide in the prevention of wound implantation with cancer cells. Lancet (1966) 1.04

The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. Int J Obes (Lond) (2012) 1.02

Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J Appl Bacteriol (1989) 1.02

Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev (2000) 1.01

In vitro fermentation of sugar beet arabinan and arabino-oligosaccharides by the human gut microflora. J Appl Microbiol (2006) 0.98

Impaired hydrogen metabolism in pneumatosis cystoides intestinalis. Gastroenterology (1993) 0.96

Cetrimide as an irrigant in wounds seeded with cancer. Cancer (1966) 0.96

Comparison of the in vitro bifidogenic properties of pectins and pectic-oligosaccharides. J Appl Microbiol (2002) 0.95

A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur J Clin Nutr (2009) 0.94

Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridization. FEMS Immunol Med Microbiol (2001) 0.94

Co-utilization of polymerized carbon sources by Bacteroides ovatus grown in a two-stage continuous culture system. Appl Environ Microbiol (1991) 0.94

Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr (2010) 0.94

In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. Br J Nutr (2000) 0.93

Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med (1999) 0.93

Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species. Appl Environ Microbiol (2001) 0.93

Efficacy studies of probiotics: a call for guidelines. Br J Nutr (1999) 0.91

A two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype Typhimurium. J Appl Microbiol (2003) 0.90

Bacteriology of the Labrador dog gut: a cultural and genotypic approach. J Appl Microbiol (2002) 0.90

Bilateral nephrectomy for malignant hypertension. Lancet (1972) 0.90

Fermentation properties of gentio-oligosaccharides. Lett Appl Microbiol (2001) 0.90

In vitro evaluation of the prebiotic activity of a pectic oligosaccharide-rich extract enzymatically derived from bergamot peel. Appl Microbiol Biotechnol (2006) 0.89

In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product stream. Appl Environ Microbiol (2005) 0.88

In vitro evaluation of the fermentation properties and potential prebiotic activity of Agave fructans. J Appl Microbiol (2009) 0.86

Uptake and cellular localization of exogenous lipids by Giardia lamblia, a primitive eukaryote. Exp Parasitol (1997) 0.86

Quantitative estimates of fermentation in the hind gut of man. Acta Vet Scand Suppl (1989) 0.86

Molecular characterisation of the gut microflora of healthy and inflammatory bowel disease cats using fluorescence in situ hybridisation with special reference to Desulfovibrio spp. J Anim Physiol Anim Nutr (Berl) (2007) 0.85

Response of porcine intestinal in vitro organ culture tissues following exposure to Lactobacillus plantarum JC1 and Salmonella enterica serovar Typhimurium SL1344. Appl Environ Microbiol (2010) 0.85

In vitro evaluation of single- and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe (2012) 0.84

In vitro measurement of the impact of human milk oligosaccharides on the faecal microbiota of weaned formula-fed infants compared to a mixture of prebiotic fructooligosaccharides and galactooligosaccharides. Lett Appl Microbiol (2011) 0.83

Negative correlation between oral malodour and numbers and activities of sulphate-reducing bacteria in the human mouth. Arch Oral Biol (1999) 0.83

Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. J Appl Microbiol (2008) 0.83

Urinary calculi and the consumption of analgesics. Br Med J (1967) 0.83

Investigation of the faecal microbiota of geriatric cats. Lett Appl Microbiol (2011) 0.83

Oligosaccharide-mediated inhibition of the adhesion of pathogenic Escherichia coli strains to human gut epithelial cells in vitro. J Food Prot (2008) 0.83

Isolation of culturable yeasts from market wines and evaluation of the 5.8S-ITS rDNA sequence analysis for identification purposes. Lett Appl Microbiol (2005) 0.82

Secondary structure analysis of the dissimilatory sulphite reductase in Desulfovibrio desulfuricans. Lett Appl Microbiol (2000) 0.82

Impotence following fractured pelvis and ruptured urethra. Br J Urol (1970) 0.82

Methods for assessing the potential of prebiotics and probiotics. Curr Opin Clin Nutr Metab Care (1999) 0.82

Synthesis of alpha-galactooligosaccharides with alpha-galactosidase from Lactobacillus reuteri of canine origin. Appl Microbiol Biotechnol (2003) 0.81

Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol (2007) 0.81

Renal transplantation from cadaver donors. Med J Aust (1968) 0.80

Comparison of the use of cetrimide, mercuric chloride, and other irrigant solutions in eradicating malignant cells from experimental operation wounds. Cancer (1970) 0.80

Development of a quantitative tool for the comparison of the prebiotic effect of dietary oligosaccharides. Lett Appl Microbiol (2003) 0.80

Growth, incidence and activities of dissimilatory sulfate-reducing bacteria in the human oral cavity. FEMS Microbiol Lett (1995) 0.80

Co-culture of Bifidobacterium adolescentis and Bacteroides thetaiotaomicron in arabinogalactan-limited chemostats: effects of dilution rate and pH. Anaerobe (1995) 0.79

In vitro evaluation of the fermentation properties of galactooligosaccharides synthesised by alpha-galactosidase from Lactobacillus reuteri. Appl Microbiol Biotechnol (2003) 0.79

Caseinoglycomacropeptide inhibits adhesion of pathogenic Escherichia coli strains to human cells in culture. J Dairy Sci (2005) 0.79

Urological management and complications of fractured pelvis and ruptured urethra. J Urol (1974) 0.79

Modulation of anti-pathogenic activity in canine-derived Lactobacillus species by carbohydrate growth substrate. J Appl Microbiol (2004) 0.79

Colon extended physiologically based extraction test (CE-PBET) increases bioaccessibility of soil-bound PAH. Environ Sci Technol (2011) 0.79

Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens. J Immunother (2001) 0.78

The effect of a model melanoidin mixture on faecal bacterial populations in vitro. Br J Nutr (1999) 0.77

Comparative analysis of intestinal tract models. Annu Rev Food Sci Technol (2015) 0.77

Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett Appl Microbiol (2002) 0.77

Some insights into the derivation and early uses of the word 'probiotic'. Br J Nutr (2003) 0.76

In vitro fermentation of mixed linkage glucooligosaccharides produced by Gluconobacter oxydans NCIMB 4943 by the human colonic microflora. Curr Issues Intest Microbiol (2006) 0.76

Potential prebiotic activity of oligosaccharides obtained by enzymatic conversion of durum wheat insoluble dietary fibre into soluble dietary fibre. Nutr Metab Cardiovasc Dis (2008) 0.75

The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding. J Hum Nutr Diet (2001) 0.75

Early function in renal allografts from cadaver donors. Aust N Z J Surg (1969) 0.75

Chemotherapy in the management of bladder tumours. Aust N Z J Surg (1969) 0.75

Physiology and biochemistry of glycyl-prolyl aminopeptidase formation in Bacteroides splanchnicus. Clin Infect Dis (1993) 0.75

Lipid chromatographic determination of nitroglycerin products in waste waters. J Chromatogr (1974) 0.75

Gastrointestinal microflora: probiotics. Adv Appl Microbiol (2006) 0.75

A clinical appraisal of methenamine hippurate in urinary tract infections. Med J Aust (1970) 0.75

In vitro effects of phosphatidylcholine and transgalactooligosaccharides on the production of 1,2-sn-diacylglycerol by Bifidobacterium longum biovar infantis. J Appl Microbiol (2008) 0.75